Bio-Rad Labs (BIO) Tops Q1 EPS by 28c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $275.60 -0.94%
EPS Growth %: -30.8%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -30.8%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $0.61, $0.28 better than the analyst estimate of $0.33. Revenue for the quarter came in at $472.8 million versus the consensus estimate of $474.6 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Utah Medical Products (UTMD) Reports Q1 EPS of $1.10
- Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
